Medivolve Inc. (MEDVF)
USD 0.0
(0.0%)
USD 0.0
(0.0%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | -2.89 Million | 6.04 Million | -9.32 Million | -10.97 Million | -4.37 Million | -384.04 Thousand |
| Net Income | -16.66 Million | -18.36 Million | -6.61 Million | -37.77 Million | -2.71 Million | -711.56 Thousand |
| Depreciation & Amortization | 400.22 Thousand | 1.54 Million | 4.82 Million | 3.17 Million | - | - |
| Deferred income taxes | 11.68 Million | 7.8 Million | 12.95 Million | 14.49 Million | - | - |
| Stock-based compensation | 112.46 Thousand | 17.55 Thousand | 3.47 Million | 2.1 Million | 156.9 Thousand | - |
| Change in working capital | 1.51 Million | 12.45 Million | -23.84 Million | 2.26 Million | -149.45 Thousand | 321.18 Thousand |
| Other non-cash items | 64.59 Thousand | 2.58 Million | -123.16 Thousand | 4.74 Million | -1.66 Million | 6333.00 |
| Investing Cash Flow | -239.36 Thousand | - | -626.31 Thousand | -5.48 Million | -918.14 Thousand | -75 Thousand |
| Investments in PPE | -239.36 Thousand | - | -42.68 Thousand | -3.53 Million | - | -75 Thousand |
| Acquisitions | -239.36 Thousand | - | -165.27 Thousand | 43.09 Thousand | - | - |
| Investment purchases | - | - | -418.35 Thousand | -3.15 Million | -918.14 Thousand | - |
| Sales/Maturities of investments | - | - | 418.35 Thousand | 680 Thousand | - | - |
| Other Investing Activities | 239.36 Thousand | - | -418.35 Thousand | 486.95 Thousand | -1 Million | -75 Thousand |
| Financing Cash Flow | -332.35 Thousand | -1.88 Million | 9.2 Million | 17.31 Million | - | - |
| Debt repayment | -1.53 Million | -1.88 Million | -11.84 Million | -2 Million | - | - |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | 4000.00 | 17.5 Million | 4.9 Million | - | - |
| Other Financing Activities | -1.36 Million | -796.1 Thousand | 3.55 Million | 14.42 Million | - | - |
| Accounts receivables | 1.47 Million | 35.79 Million | -52.76 Million | -3.28 Million | -275.32 Thousand | 364.67 Thousand |
| Accounts payables | -593.01 Thousand | -18.49 Million | 22.22 Million | 6.17 Million | 280.79 Thousand | - |
| Inventory | 117.61 Thousand | 45.28 Thousand | -72.95 Thousand | -104.02 Thousand | 1 Million | - |
| Other working capital | 520.73 Thousand | -4.89 Million | 6.76 Million | -508.74 Thousand | -1.15 Million | -43.49 Thousand |
| Cash at beginning of period | 4.27 Million | 112.39 Thousand | 851.4 Thousand | 976.00 | 4.37 Million | 4.83 Million |
| Cash at end of period | 806.21 Thousand | 4.27 Million | 112.39 Thousand | 851.4 Thousand | 976.00 | 4.37 Million |
| Capital Expenditure | -239.36 Thousand | - | -42.68 Thousand | -3.53 Million | - | -75 Thousand |
| Effect of forex changes on cash | 1.00 | - | - | - | - | - |
| Net cash flow / Change in cash | -3.46 Million | 4.15 Million | -739.01 Thousand | 850.43 Thousand | -4.37 Million | -459.04 Thousand |
| Free Cash Flow | -3.13 Million | 6.04 Million | -9.36 Million | -14.51 Million | -4.37 Million | -459.04 Thousand |
| Breakdown | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 | 2023 Q2 | 2023 Q1 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -1 Million | -16.66 Million | -8.42 Million | -3.64 Million | -1.68 Million | -2.91 Million |
| Depreciation & Amortization | 51.19 Thousand | 400.22 Thousand | 51.52 Thousand | 51.09 Thousand | 138.88 Thousand | 158.72 Thousand |
| Deferred income taxes | - | 11.68 Million | - | 2.41 Million | - | - |
| Stock-based compensation | -30.39 Thousand | 112.46 Thousand | - | 112.46 Thousand | - | - |
| Change in working capital | 596.08 Thousand | 1.51 Million | 132.66 Thousand | 259.52 Thousand | 1.69 Million | -571.5 Thousand |
| Other non-cash items | 7413.00 | 64.59 Thousand | 7.5 Million | 77.95 Thousand | 704.96 Thousand | 1.03 Million |
| Investing Cash Flow | - | -239.36 Thousand | -5292.00 | 11.78 Thousand | -245.86 Thousand | - |
| Investments in PPE | - | -239.36 Thousand | - | - | - | - |
| Acquisitions | - | -239.36 Thousand | -5292.00 | 11.78 Thousand | -245.86 Thousand | - |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | - | 239.36 Thousand | - | - | - | - |
| Financing Cash Flow | -19.84 Thousand | -332.35 Thousand | -41.34 Thousand | -19.16 Thousand | -12.76 Thousand | -259.08 Thousand |
| Debt repayment | -19.84 Thousand | -1.53 Million | -41.34 Thousand | -19.16 Thousand | -12.76 Thousand | -1.45 Million |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | - | - | - | - | - |
| Other Financing Activities | - | -1.36 Million | -20.4 Thousand | - | - | 1.2 Million |
| Accounts receivables | -33.77 Thousand | 1.47 Million | -72.16 Thousand | -92.07 Thousand | 632.61 Thousand | 1 Million |
| Accounts payables | 586.28 Thousand | -593.01 Thousand | 235.67 Thousand | 188.16 Thousand | 866.19 Thousand | -1.88 Million |
| Inventory | -937.00 | 117.61 Thousand | -197.49 Thousand | -15.09 Thousand | 33.88 Thousand | 296.32 Thousand |
| Other working capital | -9875.00 | 520.73 Thousand | 166.64 Thousand | 178.53 Thousand | 162.63 Thousand | 12.93 Thousand |
| Cash at beginning of period | 806.21 Thousand | 4.27 Million | 1.58 Million | 2.32 Million | 1.72 Million | 4.27 Million |
| Cash at end of period | 256.95 Thousand | 806.21 Thousand | 806.21 Thousand | 1.58 Million | 2.32 Million | 1.72 Million |
| Capital Expenditure | - | -239.36 Thousand | - | - | - | - |
| Effect of forex changes on cash | - | 1.00 | 1.00 | - | - | - |
| Net cash flow / Change in cash | -549.25 Thousand | -3.46 Million | -781.55 Thousand | -732.65 Thousand | 596.95 Thousand | -2.54 Million |
| Free Cash Flow | -529.4 Thousand | -3.13 Million | -734.91 Thousand | -725.27 Thousand | 855.58 Thousand | -2.28 Million |
BNORDIK-CSE
MLEDU
688595
603519
CABB
DGL